Search company, investor...

Naia Rare Diseases

Founded Year



Acquired | Acquired

About Naia Rare Diseases

Naia Rare Diseases is a development-stage biopharmaceutical company developing novel drugs for rare gastrointestinal disorders.On November 13, 2019, Naia Rare Diseases was acquired by RDD Pharma. The terms of the transaction were not disclosed.

Headquarters Location

Richmond, California,

United States

Missing: Naia Rare Diseases's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Naia Rare Diseases's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Naia Rare Diseases News

RDD Pharma to acquire Naia Rare Diseases — 3 insights

May 1, 2020

Eric Oliver - What you should know: 1. Naia is developing a short bowel syndrome treatment and has other GI drugs in the pipeline. 2. RDD Pharma expects to close the deal after its merger with Innovate Biopharmaceuticals closes, forming 9 Meters Biopharma. 3. Naia will receive a combination of cash and shares in 9 Meters Biopharma if both deals close. More articles on surgery centers:   Featured Whitepapers Copyright © 2020 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here . | Employee Access The Becker's ASC Review website uses cookies to display relevant ads and to enhance your browsing experience. By continuing to use our site, you acknowledge that you have read, that you understand, and that you accept our Cookie Policy and our Privacy Policy .

Naia Rare Diseases Frequently Asked Questions (FAQ)

  • When was Naia Rare Diseases founded?

    Naia Rare Diseases was founded in 2014.

  • Where is Naia Rare Diseases's headquarters?

    Naia Rare Diseases's headquarters is located at Richmond.

  • What is Naia Rare Diseases's latest funding round?

    Naia Rare Diseases's latest funding round is Acquired.

  • Who are the investors of Naia Rare Diseases?

    Investors of Naia Rare Diseases include RDD Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.